Cargando…
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-α2 alone (five patients) or with IFN-ω (eight patients) from a cohort of 279 patients (4.7%) aged 6...
Ejemplares similares
-
Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
por: Andreakos, Evangelos, et al.
Publicado: (2021) -
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
por: Andreakos, Evangelos, et al.
Publicado: (2021) -
Auto-anticorps anti-interférons de type I et COVID-19 sévère
por: Bastard, Paul, et al.
Publicado: (2021) -
Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
por: Hoste, Levi, et al.
Publicado: (2021) -
COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events
por: Pergent, Martine, et al.
Publicado: (2023)